Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Previously Treated Advanced Esophageal and Gastric Adenocarcinoma
NCT00985192Phase 2Completed
- Sponsor
- TRIO
- Start
- Sep 2009
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in esophageal adenocarcinoma (EAC), gastric adenocarcinoma, sponsored by TRIO. Started Sep 2009; status: completed.
02
Drugs
everolimus
03
Conditions
esophageal adenocarcinoma (EAC)gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00985192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985192.